Articles Referencing WCRX
Actavis to Buy Warner Chilcott - Analyst Blog
5/21/2013, 4:25 pm from Zacks.com in Investing, Business, Stocks
Actavis, Inc. ( ACT ) recently
announced its intention to acquire Warner Chilcott
plc ( WCRX
) in a stock-for-stock transaction worth about $8.5 billion. This
includes the assumption of... Read >>
Pre-Market Most Active for May 20, 2013 : WCRX, RDS/B, YHOO, ACT, BAC, BP, AU, NBG, GILD, ASML, WBSN, ZNGA
5/20/2013, 8:39 am from NASDAQ.com News in News Headlines, Pre-market Most Active
The NASDAQ 100
Pre-Market Indicator is to 3,026.98. The total Pre-Market
volume is currently 9,282,494 shares traded.
The following are the
most active stocks for the pre-market session :... Read >>
Earnings Beat at Warner Chilcott - Analyst Blog
5/13/2013, 10:48 am from Zacks.com in Investing, Business, Earnings, Stocks
Warner Chilcott' s ( WCRX ) first quarter
2013 earnings (excluding special items) of 92 cents per share
handsomely beat the Zacks Consensus Estimate of 85 cents. Lower
selling, general... Read >>
Pre-Market Earnings Report for May 10, 2013 : SIRO, WCRX, ERF, DRH, EVEP, BECN, MT, AWR, LXRX, HL, TRLG, STB
5/9/2013, 4:00 pm from NASDAQ.com News in News Headlines, Earnings
The following companies are expected to report earnings prior to
market open on 05/10/2013. Visit our Earnings
Calendar for a full list of expected earnings releases. Sirona Dental Systems,... Read >>
Positive Data on BioLineRx Treatment - Analyst Blog
4/18/2013, 7:12 pm from Zacks.com in Investing, Business, Stocks
BioLineRx Ltd. ( BLRX ) recently
announced encouraging results from a phase IIa study on BL-7040.
BioLineRx is developing BL-7040 for the treatment of inflammatory
bowel disease (IBD).... Read >>
Good News for Warner Chilcott - Analyst Blog
4/15/2013, 5:50 pm from Zacks.com in Investing, Business, Stocks
Warner Chilcott plc ( WCRX ) recently
received encouraging news from the US Food and Drug Administration
(FDA) when the regulatory agency approved the company's acne drug
Doryx at 200 mg... Read >>
Back to Neutral on Warner Chilcott - Analyst Blog
3/21/2013, 2:32 pm from Zacks.com in Investing, Business, Stocks
We are reverting to a Neutral recommendation on Warner
Chilcott plc ( WCRX ) from Outperform
as we believe that the stock is fairly valued at current levels
with limited upside potential... Read >>
Astellas Launches Betmiga in the UK - Analyst Blog
3/4/2013, 5:50 pm from Zacks.com in Investing, Business, Stocks
Astellas Pharma, Inc. ( ALPMY ) recently
announced the launch of its overactive bladder (OAB) drug, Betmiga
(mirabegron), in the UK. Betmiga had gained EU approval for the treatment of OAB... Read >>
Warner Chilcott Tops in 4Q - Analyst Blog
2/25/2013, 9:30 am from Zacks.com in Investing, Business, Stocks
Warner Chilcott 's ( WCRX ) fourth quarter
2012 earnings (excluding special items) of 91 cents per share
handsomely beat the Zacks Consensus Estimate of 73 cents. Lower
selling, general... Read >>
Pre-Market Earnings Report for February 22, 2013 : AGU, FLS, CHTR, EGO, PNW, IPG, NVE, ANF, WCRX, HMSY, POR, B
2/21/2013, 4:00 pm from NASDAQ.com News in News Headlines, Earnings
The following companies are expected to report earnings prior to
market open on 02/22/2013. Visit our Earnings
Calendar for a full list of expected earnings releases. Agrium Inc. ( AGU )... Read >>
Warner Chilcott Provides 2013 View - Analyst Blog
2/11/2013, 6:45 pm from Zacks.com in Investing, Business, Stocks
Warner Chilcott ( WCRX ) recently
revealed its financial guidance for 2013. The company expects to
earn $3.20-$3.30 per share on total revenues of $2.3-$2.4 billion
in 2013. While revenue... Read >>
FDA Nod for Warner Chilcott Drug - Analyst Blog
2/8/2013, 2:00 pm from Zacks.com in Investing, Business, Stocks
Recently, Warner Chilcott plc ( WCRX ) received
encouraging news when the US Food and Drug Administration (FDA)
approved its ulcerative colitis drug Delzicol (mesalamine). The
company... Read >>
After Hours Most Active for Feb 6, 2013 : T, BMY, FCX, KMI, NOK, HCBK, QQQ, ELN, GMCR, VMED, NWSA, WCRX
2/6/2013, 4:44 pm from NASDAQ.com News in News Headlines, After Hours Most Active
The NASDAQ 100
After Hours Indicator is down -1.61 to 2,744.74. The total
After hours volume is currently 36,743,274 shares traded.
The following are the
most active stocks for the after... Read >>
Wider Loss at ImmunoGen - Analyst Blog
1/28/2013, 9:16 am from Zacks.com in Investing, Business, Stocks
ImmunoGen Inc. ( IMGN ) reported second
quarter fiscal 2013 adjusted loss of 29 cents per share, wider than
both the Zacks Consensus Estimate of a loss of 24 cents and the
year-ago loss of... Read >>
Weekly Guru Bargains Highlights: WCRX, IOC, QCOR, PWE, PGH
12/30/2012, 2:59 pm from GuruFocus in Investing
According to GuruFocus updates , these stocks have declined
the most since Gurus have bought. Warner Chilcott PLC ( WCRX ): Down 28% Since
Paul Tudor Jones Bought in the Quarter Ended... Read >>